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Abstract
Background: Children with congenital heart disease (CHD) are at increased risk for behavioral, emotional, and
cognitive problems. They often have reduced exercise capacity and participate less in sports, which is associated with a
lower quality of life. Starting school may present more challenges for children with CHD and their families than for
families with healthy children. Moreover, parents of children with CHD are at risk for psychosocial problems. Therefore,
a family-centered psychosocial intervention for children with CHD when starting school is needed. Until now, the
‘Congenital Heart Disease Intervention Program (CHIP) – School’ is the only evidence-based intervention in this field.
However, CHIP-School targeted parents only and resulted in non-significant, though positive, effects as to child
psychosocial wellbeing. Hence, we expanded CHIP by adding a specific child module and including siblings, creating
the CHIP-Family intervention. The CHIP-Family study aims to (1) test the effects of CHIP-Family on parental mental
health and psychosocial wellbeing of CHD-children and to (2) identify baseline psychosocial and medical predictors for
the effectiveness of CHIP-Family.
Methods: We will conduct a single-blinded randomized controlled trial comparing the effects of CHIP-Family with care
as usual (no psychosocial intervention). Children with CHD (4–7 years old) who are starting or attending kindergarten or
primary school (first or second year) at the time of first assessment and their families are eligible. CHIP-Family consists of a
separate one-day workshop for parents and children. The child workshop consists of psychological exercises based on the
evidence-based cognitive behavioral therapy Fun FRIENDS protocol and sports exercises. The parent workshop focuses on
problem prevention therapy, psychoeducation, general parenting skills, skills specific to parenting a child with CHD, and
medical issues. Approximately 4 weeks after the workshop, parents receive an individual follow-up session. The baseline
(T1) and follow-up assessment (T2 = 6 months after T1) consist of online questionnaires filled out by the child, parents,
and teacher (T2 only). Primary outcome measures are the CBCL for children and the SCL-90-R for parents.
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Discussion: This trial aims to test the effects of an early family-centered psychosocial intervention to meet the
compelling need of young children with CHD and their families to prevent (further) problems. If CHIP-Family
proves to be effective, it should be structurally implemented in standard care.
Trial registration: Dutch Trial Registry; NTR6063 on 23 August, 2016.
Keywords: Congenital heart defects, Children, Families, Psychosocial wellbeing, Intervention, CHIP
Background
Children with congenital heart disease (CHD) are at ele-
vated risk for behavioral, emotional, and cognitive prob-
lems in childhood [1, 2], adolescence, and adulthood [3].
Previous cohort studies from our research group have
indicated that CHD-children are two times more likely
to develop psychopathology than healthy children
(16–27% versus 10% in the general population) - irre-
spective of the type of cardiac defect [4, 5]. Especially in-
ternalizing behavior problems, problems with social
contacts, and reduced quality of life have been reported
[6]. Moreover, neuropsychological problems and intellec-
tual impairments are well known in these children [7, 8]
and elevated percentages of CHD-children attending
special education (24% versus 4% in norm) have been re-
ported [3]. The most common morbidity affecting the
quality of life in school-aged children with CHD is the
combination of behavioral/emotional problems, develop-
mental delay, and school difficulties [9]. Such problems
can have long-term consequences: two long-term studies
have shown that adults with CHD overall had a lower
occupational and educational status compared with the
general population [10, 11]. Furthermore, children with
CHD often have reduced exercise capacity and partici-
pate less in exercise and sports, which has been associ-
ated with a lower quality of life [12]. It has been shown
that participation in an exercise program improves qual-
ity of life of children with CHD [13].
In addition, parental factors play a crucial role in
children’s psychosocial wellbeing [2, 14–16]. Maternal
mental health and worry have appeared to be more im-
portant predictors of psychosocial wellbeing of children
with CHD than illness severity [2, 17, 18]. Unfortunately,
parents of children with CHD are also at risk for psycho-
social problems themselves (e.g. anxiety, depression; 1
year prevalence 7–22%) [19].
Considering the above and the fact that milestones
such as starting kindergarten and primary school present
more challenges for children with CHD and their par-
ents than for families with healthy children [20], a
family-based psychosocial intervention tailored to their
needs when starting school is required [19, 21, 22]. This
need has also been expressed by parents and patients
[21, 23]. Through such an intervention, psychosocial
problems of children with CHD and their parents may
be recognized, reduced or prevented. In addition, school
functioning, emotional resilience, and sports participa-
tion of these children can be improved [21, 24]. Until
now, the only evidence-based intervention in this field is
the Congenital Heart Disease Intervention Program
(CHIP) – School [2]. The CHIP-School study aimed to
promote psychosocial wellbeing of preschoolers with
CHD indirectly by providing an intervention for their
parents. CHIP-School resulted in significant gains in ma-
ternal mental health, reduced perceived strain on the
family, and less school absence of the child. As to child
psychosocial wellbeing, only a non-significant, though
positive, trend was found [2].
A limitation of CHIP-School was that a separate child
module was not included. Therefore, in collaboration
with the original authors of the previous CHIP interven-
tion, we have translated, extended and modified CHIP,
by adding a tailored child module for CHD-children and
their siblings. The child module includes evidence-based
cognitive behavioral exercises [25] and sports exercises.
The newly developed CHIP-Family is a psychosocial
intervention for 4- to 7-year-old children who have
undergone at least one medical intervention for CHD
and are starting or attending kindergarten or primary
school (first or second year) and their families.
The aim of this study is (1) to test the effects of
CHIP-Family on parental mental health and psychosocial
wellbeing of CHD-children who are starting or attending
kindergarten or primary school and to (2) identify base-
line psychosocial and medical predictors for the effect-
iveness of CHIP-Family.
Methods
This study is a single-center, single-blinded randomized
controlled trial (RCT) comparing the effects of the
CHIP-Family intervention with care as usual (CAU; regular
medical treatment) on mental health of parents and psy-
chosocial wellbeing of young children with CHD. This RCT
is designed according to the CONSORTguidelines [26].
Inclusion and exclusion criteria
Over a one-year period (September 2016 – September
2017) children and their families living in the
Netherlands will be recruited. Eligible are all children
who (1) underwent at least one invasive procedure
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(catheter intervention or surgery) for CHD and (2) are
starting or attending kindergarten or primary school
(first or second year) at the time of first assessment (as
the children are approximately 4–7 years old). Exclusion
criteria are: (1) child’s intellectual impairment (IQ < 70)
as ascertained by previous standardized assessment or
diagnosed by a clinician, (2) insufficient mastery of the
Dutch language, and (3) prematurely born children (ges-
tational age at birth < 37 weeks) with no other CHD
than a patent ductus arteriosus.
Recruitment and procedure
Parents of 4- to 7-year-old children who receive treatment
at the department of pediatric cardiology of the Erasmus
Medical Center – Sophia Children’s Hospital and eligible
members of the Dutch Patient Association for Congenital
Heart Disease whose children receive treatment in a car-
diac centre in the Netherlands will receive an information
leaflet explaining the purpose and procedures of the study.
Before inclusion, parents will receive a verbal explanation
of the trial. After obtaining written parental informed
consent, patients are randomly allocated to the
CHIP-Family intervention or CAU group. To avoid a
delay of more than 1 month between baseline assessment
and the intervention, patients are randomized prior to the
baseline assessment. Patients are allocated to the
CHIP-Family intervention or CAU group by means of
block randomization, performed by an independent re-
searcher. Randomization will be stratified by CHD severity
(limited to no residual heart defects or moderate to severe
residual heart defects [after medical intervention]; see
Table 1) and school year (kindergarten or primary school).
To avoid bias, the researcher performing the assessments
and analyses will be blinded. Considering the nature of the
CHIP-Family intervention, it is not possible to blind the
participants and the health care professionals providing
the intervention.
Intervention
CHIP-Family consists of a parent module and a child
module. Parents and children participate in a separate, but
simultaneously given, 6-h group workshop. An overview
of the content of the workshops is given in Table 2. Over
the course of a 11-month period (Nov. 2016 – Sept. 2017)
11 workshops will be given to 3 to 5 families per
workshop.
Parent module
The parent module is based on the evidence-based
CHIP-School protocol [2].
Workshop
The parent workshop focuses on problem prevention
therapy, psychoeducation, general parenting skills, skills
specific to parenting a child with CHD (given by two se-
nior psychologists with expertise in the field; 4 h), and
medical issues (given by a pediatric cardiologist; 1 h).
The lunch break (1 h) offers families more opportunity
to interact and share (similar) experiences. During the
workshop, parents receive a manual which contains an
overview of the topics that will be covered during the
workshop and a home assignment on problem preven-
tion therapy. Parents also receive handouts and a teacher
information leaflet.
Follow-up booster session
Approximately 4 weeks after the workshop, parents re-
ceive an individual follow-up booster session with a
Table 1 Stratification factor “CHD severity”
Type 1 Type 2
Limited to no residual heart defects after medical intervention Moderate to severe residual heart defects after medical intervention
Atrial Septal Defect (ASD) ALCAPA (Anomalous Left Coronary
Artery from the Pulmonary Artery)
Patent Ductus Arteriosus Aortic Valve Stenosis
Pulmonary valve stenosis Atrioventricular Septal Defect (AVSD)
Total Anomalous Pulmonary
Venous Connection
Coarctation of the Aorta
Ventricular Septal Defect (VSD) Complex Biventricular (e.g. Truncus
Arteriosus, aortic arch defects)
Double Inlet Ventricle – Fontan circulation
Ebstein’s Anomaly
Subvalvular Aortic Stenosis
Tetralogy of Fallot (TOF)
TOF with MAPCA (Main Aorta to
Pulmonary Connecting Artery)
Transposition of the Great Arteries
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psychologist who was present during the parent work-
shop and a psychologist who was present during the
child workshop. Questions or worries that may have
come up after the workshop regarding their child with
CHD or their family members are discussed. Also, as-
pects of the workshop which have been (most) helpful
for parents and will be helpful in the future are
reviewed. Moreover, the session focuses on the problem
prevention home assignment and on how to promote fu-
ture use of problem prevention therapy.
Child module
To normalize participation in the workshop and to
stimulate practice at home, each child is allowed to bring
a 4- to 10-year-old sibling or friend. The psychological
exercises (given by two junior psychologists; 4 h) are
based on the evidence-based cognitive behavioral ther-
apy Fun FRIENDS protocol [25]. The exercises are pro-
vided in a playful manner and focus on regulating
emotions, relaxation, promoting autonomy, strengthen-
ing self-esteem, making friends, problem solving skills,
and positive thinking. The playful, age-attuned sports ex-
ercises (given by a physiotherapist and assistant physio-
therapist; 1 h) are based on a standardized training
program. Previous research has shown that these exer-
cises are effective in improving the quality of life in chil-
dren with CHD [13].
Training and protocol adherence
CHIP-Family is performed in a standardized manner.
Prior to the workshops, four senior and five junior psy-
chologists receive a one-day CHIP-training by develop-
mental psychologists Prof. Dr. McCusker and Dr.
Doherty, developers of the original CHIP-protocol. To
ensure consistency, the same senior and junior psycholo-
gist will be present at each workshop. In both the parent
and child workshops, another psychologist will be
present. Master’s students in Psychology will assess
treatment integrity during the parent and child work-
shop through a standardized form. Follow-up sessions
are audiotaped and treatment integrity is assessed
through a standardized form afterwards.
Outcome measures
An overview of all variables and questionnaires per as-
sessment moment is given in Table 3. All questionnaires
are (inter)nationally validated and Dutch normative data
is available. Children and their families are enrolled into
the study in groups of 6 to 10 families (3 to 5 families in
the CHIP-group and 3 to 5 families in the CAU group).
In both the CHIP-Family and the CAU condition, the
first assessment will take place within 2 weeks before the
CHIP-Family intervention (T1) and the follow-up
post-assessment (T2) will take place 6 months after T1.
Patients who are randomized into the CHIP-Family
intervention group complete a social validity
Table 2 Outline of the CHIP-Family workshops
Health care professional(s) Content
Parent workshop
Psychologists • Problem prevention therapy [48]. A DO ACT acronym is applied:
Define problem and turn into a specific goal; Option brainstorm;
Assess pros and cons of various options; Choose a strategy;
Take action and evaluate
• Psychoeducation
• General parenting skills
• Specific parenting skills for children with CHD
Pediatric cardiologist • Information on medical diagnoses, treatments,
future issues (e.g., career, pregnancy), insurance,
and healthy living (e.g., sports, diet)
Child workshop
Psychologists • Relaxation
• Promoting autonomy
• Strengthening self-esteem
• Making friends
• Problem solving skills
• Positive thinking
Physiotherapists • Playful, age-attuned sports exercises: warming-up,
fitness, gross motor skills, balance, aiming, and catching
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questionnaire assessing satisfaction with regards to the
CHIP-program within 2 weeks after the intervention and
at T2. All questionnaires are completed at home through
a secure website.
Primary outcomes
Child behavioral/emotional problems The problem
section of the Child Behavior Checklist (CBCL) [27] 1,½-5
(100 items; for 4- and 5-year-olds) and CBCL/6–18 (120
items; for 6- and 7-year-olds) will be used to obtain stan-
dardized parent reports of emotional and behavioral prob-
lems in their child. Response categories range from 0 to 2,
with higher scores indicating more emotional and/or be-
havioral problems. Adequate reliability and validity have
been reported [28].
Parental mental health The Symptom Checklist-90-Re-
vised (SCL-90-R) [29] is a self-report scale (90 items; re-
sponse categories: 1–5, higher score indicates more
symptoms) which assesses 9 primary symptom dimen-
sions: Somatization, Obsessive-Compulsive, Interper-
sonal Sensitivity, Depression, Anxiety, Hostility, Phobic
Anxiety, Paranoid Ideation, and Psychoticism. Adequate
reliability and validity have been reported for the Dutch
version [29].
Secondary outcomes
School days sick/absent Through the Rotterdam
Quality of Life interview [30] parents and teachers will
be asked how many days the child was absent from
school and what the reasons for absence were.
Table 3 Assessment instruments and moments of assessment
Instrument Variable Assessment moment
T1 Direct
follow-up
T2
Primary outcomes
Child Behavior Checklist (CBCL) [32] Child behavioral/emotional problems M, F M, F
Symptom Checklist-90-Revised (SCL-90-R) [29] Parental mental health M, F M, F
Secondary outcomes
Rotterdam Quality of Life interview [30] School days sick/absent M, F M, F, T
Rotterdam Knowledge Questionnaire [31] Disease-specific knowledge
and illness perception
M, F M, F
Teacher Report Form (TRF) [32] School functioning - T
Behavior Rating Inventory of Executive Functioning (BRIEF) [34, 35]
or BRIEF-Preschool Version (BRIEF-P) [36]
Executive functioning M, F M, F, T
Adjusted Groningen Enjoyment Questionnaire [37] Sports participation, enjoyment
of physical activity
M, F M, F, T
2 sports-related questions Sports participation, enjoyment
of physical activity
C C
Penn State Worry Questionnaire (PSWQ) [49] Parental worry M, F M, F
Nijmeegse Ouderlijke Stress Index verkort (NOSIK) [40] Parental stress M, F M, F
Stress thermometer (DT-P) [50] Parental stress M, F M, F
Child Health Questionnaire (CHQ-PF50) [51] Quality of life of child and sibling M, F M, F
Short-form (36) Health Survey (SF-36) [52] Quality of life of parents M, F M, F
Family Assessment Device, general functioning subscale (FAD) [53] Family functioning M, F M, F
Medical record Medical consumption R R
Social validity questionnaire Satisfaction, attendance, and
completion of CHIP-Family
– M, F M, F
Predictor variables
Rotterdam Quality of Life interview [30] Demographic variables M, F –
Medical record Cardiac diagnosis R R
Life event subscale of the Cognitive Emotion Regulation Questionnaire,
child version (CERQ-k) [44]
Life events M, F M, F
M Mother, F Father, C Child, T Teacher, R Medical records
T1 = baseline, Direct follow-up = within 2 weeks after CHIP-Family intervention (only for participants in intervention group), T2 = follow-up, 6 months after T1
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Disease-specific knowledge and illness perception
The Rotterdam Knowledge Questionnaire for Congenital
Heart Disease [31] is used to assess parents’ knowledge
about CHD and parents’ illness perception.
School functioning The Dutch version of the Teacher’s
Report Form (C-TRF) 1½-5 (100 items) [32] or the TRF/
6–18 (120 items) [33] will be completed by the teacher
of the child. The TRF assesses problem behavior (at
school). Response categories range from 0 to 2, with
higher scores indicating more emotional and/or behav-
ioral problems.
Executive functioning The Dutch Behavior Rating
Inventory of Executive Functioning (BRIEF) [34, 35] (63
items; 2–5 years) and BRIEF-Preschool version
(BRIEF-P) [36] (86 items; 5–18 years) will be used to as-
sess executive functioning skills in daily life. Response
categories range from 0 to 2, with higher scores indicat-
ing more problems.
Enjoyment of leisure-time physical activity The
Groningen Enjoyment Questionnaire (GEQ; 10 items;
response categories 1–3, higher score indicates more en-
joyment) [37, 38] is adjusted for parents and teachers and
assesses enjoyment of physical activity. Children them-
selves answer two questions to assess how often they en-
gage in physical activity and to assess enjoyment of
physical activity.
Parental worry The Penn State Worry Questionnaire
(PSWQ; 16 items; response categories 1–5, higher score
indicates higher level of worry) [39] assesses the exces-
siveness and uncontrollability of parental worry.
Parenting stress The Nijmeegse Ouderlijke Stress Index
verkort (NOSIK) [40, 41] (25 items; response categories
1–6, higher score indicates higher level of stress) mea-
sures stress due to parenting. Parents will also complete
the Distress Thermometer (DT-P) [42] (40–42 items),
which consists of a problem list and a thermometer on
which parents are asked to rate their overall distress.
Quality of life of children and siblings The Child
Health Questionnaire Parent Form-50 (CHQ-PF50; 50
items) [43] is used to assess quality of life of the child
with CHD and, if possible, of one sibling.
Parental quality of life The Short-form (36) Health
Survey (SF-36) [44] (36 items; score per domain 0–100,
higher score indicates less disability) assesses eight
health status domains: physical functioning, role limita-
tions due to physical problems, bodily pain, general
health, social functioning, role limitations due to emo-
tional functioning, mental health, and vitality.
Family functioning The general functioning subscale of
the Family Assessment Device (FAD) [45] (12 items;
response categories 1–4, higher total score indicates
poorer functioning) assesses problem areas of family
functioning.
Social validity Through a questionnaire, parents will be
asked about their satisfaction regarding CHIP-Family.
Furthermore, data on attendance and completion of
CHIP-Family will be recorded.
Predictors
Demographic variables Demographic variables such as
age, gender, and socio-economic status will be assessed
through the Rotterdam Quality of Life interview [30].
Medical variables Information about cardiac diagnosis,
surgery, and intrusive procedures will be retrieved from
medical records.
Life events The ‘life events’ subscale of the Cognitive
Emotion Regulation Questionnaire child version
(CERQ-k) [44] is adjusted as such that parents can an-
swer the questions about their child.
Sample size calculation
To conduct a repeated measures ANOVA with two assess-
ment moments, Cohen’s d of 0.6, an alpha of .05
(two-tailed), and a power of .80, a sample size of 90 patients
is needed, of which 45 patients in the intervention group.
Statistical analysis
To test the effectiveness of CHIP-Family on the primary
outcome measures (for parents: mental health [SCL-90-R];
for children: behavioral/emotional problems [CBCL]) re-
peated measures ANOVAs will be conducted, for parental
and child outcomes separately. Group (CHIP-Family ver-
sus CAU) will be the between-subjects variable and as-
sessment (T1 versus T2) will be the within-subjects
variable. Likewise, repeated measures ANOVAs will be
conducted for the secondary outcome measures.
Additional regression analyses will be conducted to in-
vestigate in what way demographic factors, medical fac-
tors, and life events moderate the effect of CHIP-Family
on the primary outcome measures.
Discussion
Several cohort and longitudinal studies have shown that
there is a compelling need for a family-based psycho-
social intervention for children with CHD and their
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families [1–3, 18–21]. Since key milestones such as start-
ing kindergarten and primary school present more chal-
lenges for children with CHD and their parents than for
families with healthy children [20], an intervention tai-
lored to their needs when starting school is needed. The
previously examined CHIP-School intervention [2], the
only evidence-based psychosocial intervention for this
population to date, significantly improved maternal
mental health, diminished perceived strain on the family,
and resulted in less school absence of the child.
However, CHIP-School targeted parents only, aiming for
an indirect effect on child psychosocial wellbeing.
CHIP-School resulted in a non-significant, though posi-
tive, increase in child psychosocial wellbeing.
To improve these outcomes, we will modify and extend
CHIP by adding a tailored child module for children with
CHD and their siblings, thereby creating the CHIP-Family
intervention. The child module consists of evidence-based
cognitive behavioral and sports exercises. We will conduct
an RCT to examine the effect of the innovated
CHIP-Family intervention on parental mental health and
psychosocial wellbeing of young children with CHD.
This study has several strengths. Firstly, if CHIP-Fam-
ily proves to be effective, this would be the first
evidence-based psychosocial intervention for young
children with CHD and their families, thus meeting the
previously described need for an intervention. Secondly,
as recommended by the guidelines of the Association
for European Pediatric Cardiology working group [22],
CHIP-Family provides early intervention. CHIP-Family
aims to reduce and prevent psychosocial problems. As
mental health problems in childhood may persist into
adulthood [22, 46], the prevention of psychosocial
problems is important. Thirdly, CHIP-Family is a fam-
ily-centered intervention. It is widely acknowledged
that family functioning and parental factors play an
important role in children’s development [2, 14, 15]. As
parents of children with CHD are at risk for psycho-
social problems [19], a family-centered intervention
may reduce their problems [47]. This, in turn, may en-
hance family functioning. Furthermore, siblings are in-
volved in the workshop and receive attention from the
hospital staff, which normalizes the position of the
child with CHD.
In conclusion, this intervention aims to fulfill the need
for an evidence-based family-centered psychosocial
intervention for children with CHD and their families. If
CHIP-Family proves to be effective in improving paren-
tal mental health and psychosocial wellbeing of children
with CHD, it should be structurally implemented in
standard care.
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